Max Health is happy to report that is has been awarded the tender for Neostigmine Metisulfate injection 2.5mg/mL in 1mL. This product is manufactured by our German supplier, Hameln. Neostigmine Metisulfate will be listed in both sections H and B of the Pharmaceutical Schedule, and will enjoy Principal Supply Status until 30 June 2024.
This change in subsidy will occur on October 1st 2021.
Distribution of all Max Health products, including Neostigmine Metisulfate, will be handled by Onelink. These can be ordered from Onelink on:
Phone: 0800 70 80 60
Fax: 0800 26 69 60
E-mail: customerservices@onelink.co.nz
Neostigmine Metisulfate Injection details are as follows:
Name: Neostigmine Metisulfate Injection
Strength: 2.5mg/mL, 1mL amps x 10
Onelink Code: PHAT58
Pharmacode: 2599996
Price: POA